2016 started off with the publication of the updated Clinical Practice Guideline: Chiropractic Care for Low Back Pain in the January issue of JMPT.
Thanks to a generous grant by the Michigan Chiropractic Foundation, the Clinical Compass put out a call for proposals for a paper to address the possible role of chiropractic care in stemming the opioid epidemic. The proposal by James Whedon, DC, MA was accepted and the paper will be presented at the upcoming DC2017 conference in Washington, D.C.
The Clinical Compass initiated talks with the Canadian Chiropractic Guideline Initiative (CCGI) to collaborate on guidelines. Our goal is to focus efforts on dissemination of information to the profession without duplication of effort.
The Journal of Evidence-Based Complementary & Alternative Medicine published a special issue in April of 2016 on evidenced based chiropractic research. The guest editors for this issue were Clinical Compass Research Commission Chair Cheryl Hawk, DC, PhD and Board Chair Jay Greenstein, DC, CCSP, CGFI-L1.
ChiroCode Institute has again included the Algorithms for the Chiropractic Management of Acute and Chronic Spine-Related Pain in their popular ChiroCode DeskBook. Our Research Commission Chair Cheryl Hawk, DC, PhD, updates our Rapid Response Resource Center (R3C) yearly The R3C is an open access virtual library at www.clinicalcompass.org.
Dr. Hawk started work on a much-needed paper on the shoulder. This project will be completed and ready for publication in the second quarter of 2017.
In a landmark case in Federal Court in South Carolina, Dr. Farrel Grossman, Chair of FCLB, utilized the Algorithms paper to defend a DC being sued by an insurance company for not meeting the standard of care. Dr. Grossman testified using the Algorithms and informed the Court that the DC had met the standard of care. The defendant won the case. This was the first time in history that the Algorithms have been entered into evidence supporting chiropractic in Federal Court!
Why your support matters…Chiropractic is the safest and most effective treatment available for a wide-range of neuromusculoskeletal conditions; however, payors, business and industry leaders, legislators and the public in general are still largely unaware of its efficacy in terms of both costs and treatment effectiveness. Many gaps still exist in the literature, and CCGPP is in need of significant funding in order to grant money to the colleges and other synergistic organizations so they can continue their important work.